Latest Science and Health News: A Rare Case
Vertex Pharmaceuticals (NASDAQ: VRTX) and its partners have catalyzed a shift in rare disease treatment following reports of a successful, rare clinical outcome in gene-editing therapy. This breakthrough signals a ... Read More